Does SECUKINUMAB Cause Conjunctival hyperaemia? 10 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Conjunctival hyperaemia have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
10
Reports of Conjunctival hyperaemia with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Conjunctival hyperaemia From SECUKINUMAB?
Of the 10 reports, 2 (20.0%) required hospitalization.
Is Conjunctival hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Conjunctival hyperaemia?
NETARSUDIL (240)
LAMOTRIGINE (120)
LATANOPROST\NETARSUDIL (98)
IBUPROFEN (95)
ACETAMINOPHEN (67)
DUPILUMAB (66)
DICLOFENAC (51)
BEVACIZUMAB (50)
RITUXIMAB (50)
DEXAMETHASONE\TOBRAMYCIN (44)
Which SECUKINUMAB Alternatives Have Lower Conjunctival hyperaemia Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG